Could a drug cocktail boost survival in early oral cancer?
NCT ID NCT07267286
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 2 trial tests whether adding the immunotherapy drug tirellizumab plus chemotherapy before standard surgery can improve outcomes for people with early oral squamous cell carcinoma. Sixty participants will be randomly assigned to either the drug combo plus surgery or surgery alone. The main goal is to see if the combo increases the number of patients who remain free of cancer-related events for two years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- tirellizumab (a PD-1 inhibitor) combined with carboplatin and albumin-bound paclitaxel
- What this could lead to
- If it works, this could improve survival and reduce recurrence for people with early oral cancer, offering a more effective treatment option.
- What could go wrong
- This is a small, early-phase exploratory study with only 60 participants. The combination therapy may cause side effects like immune reactions or infections, and it may not prove better than standard surgery alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HNSCC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sun yat-sen memorial hospital
Guangzhou, Guangdong, 510000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a One-Two punch of radiation and immunotherapy shrink head and neck tumors before surgery?
- Can a glowing drug light up head and neck tumors?
- Can a Two-Target antibody shrink Hard-to-Treat cancers?
- New drug combo aims to shrink oral cancers before surgery
- Could a laser beam stop chemo mouth sores?
- Modified herpes virus joins forces with immunotherapy to attack head and neck tumors